longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

The concept of innovative drugs warmed up in the afternoon, with CSBIO rising over 15%, reaching a historic high

Zhitong
Jun 6, 2025 at 05:27 AM

The concept of innovative drugs has rebounded, with CSBIO rising over 15%, reaching a new historical high. Maiwei Biotech increased by over 10%, Anglikon hit the daily limit, and Sinocelltech, Wanbangde, XinNuoWei, and Haichuang Pharmaceutical all surged

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Sep 8, 2026 at 12:14 PMAI-era DCI: Beyond the chip, compete as a network. Is there a China play?

Related Stocks

Sinocelltech

Sinocelltech

SH688520

-1.02%

CSBIO

CSBIO

SZ300255

-2.82%

ALK

ALK

SZ002940

LongbridgeAI